Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenomatous Polyposis Coli × Endoscopy × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polyps 2 Hyperplasia 2 Carcinoma 1 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Ursodeoxycholic Acid 2 Endoscopy 1 Eicosapentaenoic Acid 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed

58 enrolled 12 charts

Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡